SELECTION OF BREAST-CANCER PATIENTS FOR ADRENALECTOMY OR HYPOPHYSECTOMY BY DETERMINATION OF URINARY 17-HYDROXYCORTICOSTEROIDS AND ÆTIOCHOLANOLONE